SAB Biotherapeutics, Inc. (SABS) stock
Close on Nov 13, 2026Market cap $269.32MP/E –Yield –
SAB Biotherapeutics statistics
59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.28
- 2.22
Share statisticsIndustry
- Shares Change (QoQ)
- 9.16%
- 0.50%
- Float
- 63M
- 49M
- Shares Held by Insiders
- 30.2%
- 11.7%
- Shares Held by Institutions
- 75.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- 4.66%
- -0.80%
- Short % of Float
- 7.92%
- 9.01%
- Short % of Shares Outstanding
- 5.52%
- 6.30%
- Days to Cover
- 8.28
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $5.15
- –
- 52-Week Low
- $2.44
- –
- 20-Day Moving Average
- $3.04
- –
- 50-Day Moving Average
- $3.12
- –
- 200-Day Moving Average
- $3.63
- –
- Average True Range (14)
- $0.22
- –
- Price Change (1 Week)
- -2.31%
- -1.15%
- Price Change (1 Month)
- 14.3%
- -4.87%
- Price Change (3 Months)
- -21.5%
- -21.0%
- Price Change (6 Months)
- -20.0%
- -20.6%
- Price Change (YTD)
- -20.9%
- -23.6%
- Price Change (1 Year)
- -13.2%
- -22.4%
- Price Change (3 Years)
- -67.5%
- -29.5%
- Price Change (5 Years)
- -96.8%
- -77.9%
- Average Volume (10 Days)
- 754,167
- –
- Average Volume (20 Days)
- 679,577
- –
- Average Volume (90 Days)
- 552,869
- –
- Relative Volume
- 1.19
- 0.70
- Relative Strength Index (14)
- 46.1
- 43.4
- Volatility (1 Year)
- 61.6%
- 80.1%
- Beta (5 Years)
- 1.39
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -42.8%
- -49.9%
- Return on Assets (ROA)
- -38.4%
- -40.6%
- Return on Invested Capital (ROIC)
- -83.4%
- -32.9%
- Return on Capital Employed (ROCE)
- -38.5%
- -37.9%
Financial positionIndustry
- Current Ratio
- 7.28
- 3.30
- Quick Ratio
- 7.03
- 2.39
GrowthIndustry
- Net Income Growth (YoY)
- -529.7%
- -14.4%
EfficiencyIndustry
- Profits Per Employee
- -$936.28K
- -$689.41K
- Employee Count
- 86
- 74
- WACC
- 12.0%
- 10.2%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $104.05M
- $17.76M
- Net Cash Per Share
- $1.14
- $0.80
- Equity (Book Value)
- $210.92M
- $53.89M
- Book Value Per Share
- $2.32
- $1.50
- Tangible Book Value
- $210.92M
- $27.13M
- Working Capital
- $92.94M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -29.9%
- -21.8%
Scores and fair valueIndustry
- Altman Z-Score
- 4.78
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | SABS | S&P 500 | Difference | SABS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.4% | -3.0% | +13.5 pts | ||
| 3 months | -21.1% | -2.8% | −18.3 pts | ||
| Year to date | -20.9% | +11.5% | −32.3 pts | ||
| 1 year | -4.5% | +13.5% | −18.0 pts | ||
| 3 years | -68.2% | +77.7% | −145.9 pts | -31.7% | +21.1% |
| 5 years | -96.8% | +72.6% | −169.4 pts | -49.8% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M SABS shares were sold short on Oct 30, 2026, up 4.7% from the previous report, or 7.92% of the shares available to trade. At recent volumes it would take 8.3 days to buy them back. Over the last 20 sessions, 39.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,026,127 | +4.7% | 606,985 | 8.3 |
| Oct 15, 2026 | 4,802,296 | +11.9% | 692,960 | 6.9 |
| Sep 30, 2026 | 4,291,173 | +19.1% | 860,642 | 5.0 |
| Sep 15, 2026 | 3,603,065 | -12.6% | 269,533 | 13.4 |
| Aug 31, 2026 | 4,121,534 | -11.0% | 326,707 | 12.6 |
| Aug 14, 2026 | 4,630,138 | -0.7% | 420,784 | 11.0 |
| Jul 31, 2026 | 4,660,515 | +6.5% | 520,581 | 8.9 |
| Jul 15, 2026 | 4,376,175 | +16.0% | 464,551 | 9.4 |
| Jun 30, 2026 | 3,773,336 | +31.2% | 1,399,986 | 2.7 |
| Jun 15, 2026 | 2,876,593 | +8.8% | 851,562 | 3.4 |
| May 29, 2026 | 2,644,665 | -3.7% | 396,248 | 6.7 |
| May 15, 2026 | 2,746,317 | +13.6% | 1,563,731 | 1.8 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?